ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
藥捷安康-B
140.800
-2.400
-1.68%
手動刷新
成交量：
71.81萬
成交額：
1.02億
市值：
558.98億
市盈率：
-179.20
高：
145.900
開：
143.300
低：
137.000
收：
143.200
52周最高：
679.500
52周最低：
20.200
股本：
3.97億
香港流通股本：
3.02億
量比：
0.25
換手率：
0.24%
股息：
- -
股息率：
- -
每股收益(LYR):
-0.786
淨資產收益率：
-39.08%
總資產收益率：
-21.10%
市淨率：
87.93
市盈率(LYR):
-179.20
市銷率:
- -
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字：
藥捷安康-B
交易所：
SEHK
成立時間：
2014
員工人數：
121
公司地址：
Building 9, Accelerator Phase 2,3rd Floor,Biotech and Pharmaceutical Valley,Jiangbei New Area,Nanjing,Jiangsu Province,China
官網：
http://www.transtherabio.com
郵編：
210032
電話：
86 25 5821 6200
傳真：
- -
簡介：
藥捷安康（南京）科技股份有限公司是一家從事生物製藥的中國公司，主要專註於發現及開發腫瘤、炎症及心臟代謝疾病小分子創新療法。該公司的核心產品Tinengotinib是一種處於註冊臨床階段的內部發現和開發的MTK抑製劑，適用於某些複發或難治的耐藥實體瘤。該公司的腫瘤產品線包括TT-00973（針對 AXL）、TT-01488（用於血液系統惡性腫瘤）、TT-01688（用於炎症性疾病）和 TT-00920（用於慢性心力衰竭）。這些產品能夠對多種癌症類型（包括前列腺癌、肝癌、乳腺癌和BTC）產生療效。它還可用於治療肝細胞癌、乳腺癌、膽道癌和Pan-FGFR實體瘤。
董事
名稱
職位
吳永謙
董事長，執行董事，戰略委員會主席，提名委員會委員
吳笛
執行董事
徐海音
獨立非執行董事，戰略委員會委員，薪酬與考核委員會委員，提名委員會主席
鄭哲蘭
獨立非執行董事，薪酬與考核委員會主席，提名委員會委員，審核委員會委員
李書湃
獨立非執行董事，審核委員會主席
賈中新
非執行董事，戰略委員會委員，薪酬與考核委員會委員，審核委員會委員
易華
非執行董事
趙衛麗
監事會主席，職工代表監事
梅江華
股東代表監事
龐亞京
股東代表監事
股東
名稱
職位
吳永謙
首席執行官
吳笛
副總裁，財務負責人
馮潔
董事會秘書，聯席公司秘書
黃荻
聯席公司秘書
樊菁
首席醫療官
崔松喜
運營副總裁
彭鵬
項目管理副總裁
盛澤娟
生物副總裁
孫彩霞
臨床執行總監
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02617/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"藥捷安康-B","latestPrice":140.8,"timestamp":1759133289390,"preClose":143.2,"halted":0,"volume":718122,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7857250640433961,"marketStatus":"未開盤","change":-2.4,"latestTime":"09-29 16:08:09","open":143.3,"high":145.9,"low":137,"amount":101534190,"amplitude":0.062151,"askPrice":140.9,"askSize":3500,"bidPrice":140.8,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.677840132841989,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1759195800000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":143.2,"openAndCloseTimeList":[[1759109400000,1759118400000],[1759122000000,1759132800000]],"volumeRatio":0.250171,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.785725,"volumeRatio":0.250171,"shares":397000000,"dividePrice":0,"high":145.9,"amplitude":0.062151,"preClose":143.2,"low":137,"week52Low":20.2,"pbRate":"87.93","week52High":679.5,"institutionHeld":0,"latestPrice":140.8,"committee":-0.272727,"eps":-0.7857250640433961,"divideRate":0,"volume":718122,"delay":0,"ttmEps":-0.677840132841989,"open":143.3,"prevYearClose":13.15,"prevWeekClose":143.2,"prevMonthClose":54.15,"prevQuarterClose":30.15,"fiveDayClose":147.7,"twentyDayClose":58,"sixtyDayClose":32.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-09-26","current":-207.729231,"percent":0.057971,"low":-380.446233,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"high":-17.403134,"avg":-77.538728,"sd":65.208791,"marketCap":56835741045},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045}],"updateTime":1759169837949},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":404671245,"yearFounded":2014,"employeeNum":121,"address":"Building 9, Accelerator Phase 2,3rd Floor,Biotech and Pharmaceutical Valley,Jiangbei New Area,Nanjing,Jiangsu Province,China","zipCode":"210032","officePhone":"86 25 5821 6200"},"stockCompanyDetail":{"websiteUrl":"http://www.transtherabio.com","stockEarnings":[{"period":"1week","weight":-0.0467},{"period":"1month","weight":1.6002},{"period":"3month","weight":3.67},{"period":"6month","weight":9.7072},{"period":"ytd","weight":9.7072}],"compareEarnings":[{"period":"1week","weight":0.0106},{"period":"1month","weight":0.0616},{"period":"3month","weight":0.106},{"period":"6month","weight":0.1474},{"period":"1year","weight":0.2903},{"period":"ytd","weight":0.3272}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"藥捷安康（南京）科技股份有限公司是一家從事生物製藥的中國公司，主要專註於發現及開發腫瘤、炎症及心臟代謝疾病小分子創新療法。該公司的核心產品Tinengotinib是一種處於註冊臨床階段的內部發現和開發的MTK抑製劑，適用於某些複發或難治的耐藥實體瘤。該公司的腫瘤產品線包括TT-00973（針對 AXL）、TT-01488（用於血液系統惡性腫瘤）、TT-01688（用於炎症性疾病）和 TT-00920（用於慢性心力衰竭）。這些產品能夠對多種癌症類型（包括前列腺癌、肝癌、乳腺癌和BTC）產生療效。它還可用於治療肝細胞癌、乳腺癌、膽道癌和Pan-FGFR實體瘤。","exchange":"SEHK","name":"藥捷安康-B","nameEN":"TRANSTHERA-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":{"directors":[{"name":"吳永謙","position":"董事長，執行董事，戰略委員會主席，提名委員會委員"},{"name":"吳笛","position":"執行董事"},{"name":"徐海音","position":"獨立非執行董事，戰略委員會委員，薪酬與考核委員會委員，提名委員會主席"},{"name":"鄭哲蘭","position":"獨立非執行董事，薪酬與考核委員會主席，提名委員會委員，審核委員會委員"},{"name":"李書湃","position":"獨立非執行董事，審核委員會主席"},{"name":"賈中新","position":"非執行董事，戰略委員會委員，薪酬與考核委員會委員，審核委員會委員"},{"name":"易華","position":"非執行董事"},{"name":"趙衛麗","position":"監事會主席，職工代表監事"},{"name":"梅江華","position":"股東代表監事"},{"name":"龐亞京","position":"股東代表監事"}],"executives":[{"name":"吳永謙","position":"首席執行官"},{"name":"吳笛","position":"副總裁，財務負責人"},{"name":"馮潔","position":"董事會秘書，聯席公司秘書"},{"name":"黃荻","position":"聯席公司秘書"},{"name":"樊菁","position":"首席醫療官"},{"name":"崔松喜","position":"運營副總裁"},{"name":"彭鵬","position":"項目管理副總裁"},{"name":"盛澤娟","position":"生物副總裁"},{"name":"孫彩霞","position":"臨床執行總監"}]}}}